Synopsis of recent research by authors named "Sarah Dewilde"
- Sarah Dewilde's recent research primarily focuses on myasthenia gravis (MG), particularly the efficacy, measurement, and patient-reported outcomes related to treatments like efgartigimod, utilizing data from clinical trials and observational studies.
- Key findings include the demonstrated long-term benefits of efgartigimod in enhancing patient quality of life, as assessed by validated scales like the Myasthenia Gravis-Activities of Daily Living (MG-ADL) and EQ-5D-5L.
- Dewilde also investigates the psychometric properties and scoring of the MG-ADL, aiming to better understand its validity and reliability in clinical assessments, while addressing the discrepancies between patient and physician-reported outcomes in MG.
